Randomized Trialhigh evidence
Middle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Patients With Chronic Subdural Hematoma: A Randomized Clinical Trial.
JAMA neurology·June 15, 2026·PMID 42295790
Why it mattersThis is the first randomized trial demonstrating that adjunctive MMAE with n-BCA reduces hematoma recurrence and reoperation in chronic subdural hematoma without increasing adverse events, offering a minimally invasive option to improve outcomes in a condition with high recurrence rates.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled